Cargando…
Effect of COVID-19 Pandemic on Invasive Pneumococcal Disease in Children, Catalonia, Spain
We analyzed the effect of COVID-19 on healthcare demand and invasive pneumococcal disease in children in Catalonia, Spain. Compared with 2018–2019, we noted large reductions in healthcare activities and incidence of invasive pneumococcal disease in 2020. These changes likely resulted from nonpharmac...
Autores principales: | Ciruela, Pilar, Soldevila, Núria, García-Garcia, Juan José, González-Peris, Sebastià, Díaz-Conradi, Alvaro, Redin, Alba, Viñado, Belén, Izquierdo, Conchita, Muñoz-Almagro, Carmen, Domínguez, Angela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9622259/ https://www.ncbi.nlm.nih.gov/pubmed/36220135 http://dx.doi.org/10.3201/eid2811.211741 |
Ejemplares similares
-
Changes in Invasive Pneumococcal Disease in the Paediatric Population in the Second COVID-19 Pandemic Year
por: Izquierdo, Conchita, et al.
Publicado: (2023) -
Invasive pneumococcal disease rates linked to meteorological factors and respiratory virus circulation (Catalonia, 2006–2012)
por: Ciruela, Pilar, et al.
Publicado: (2016) -
Serotype and clonal distribution dynamics of invasive pneumococcal strains after PCV13 introduction (2011-2016): Surveillance data from 23 sites in Catalonia, Spain
por: Ludwig, Guillermo, et al.
Publicado: (2020) -
Failures of 13-Valent Conjugated Pneumococcal Vaccine in Age-Appropriately Vaccinated Children 2–59 Months of Age, Spain
por: Hernández, Sergi, et al.
Publicado: (2020) -
Effectiveness of the 13-valent pneumococcal conjugate vaccine in preventing invasive pneumococcal disease in children aged 7-59 months. A matched case-control study
por: Domínguez, Ángela, et al.
Publicado: (2017)